.
BioEnterprise

Cleveland HeartLab Acquires MIRISK Cardiovascular Disease Assessment Tool Technology

Cleveland HeartLab has acquired MIRISK, a cardiovascular disease assessment tool developed at Stanford University that can determine whether a patient is at risk for a heart attack.

Read More  >